Home » Stocks » Recro Pharma

Recro Pharma, Inc. (REPH)

Stock Price: $4.13 USD 0.04 (0.98%)
Updated Aug 3, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 97.33M
Revenue (ttm) 95.93M
Net Income (ttm) -24.34M
Shares Out 23.57M
EPS (ttm) -1.07
PE Ratio n/a
Forward PE 18.25
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 3, 2020
Last Price $4.13
Previous Close $4.09
Change ($) 0.04
Change (%) 0.98%
Day's Open 4.11
Day's Range 4.04 - 4.24
Day's Volume 193,052
52-Week Range 3.99 - 19.21

More Stats

Market Cap 97.33M
Enterprise Value 190.29M
Earnings Date (est) Aug 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 23.57M
Float 19.06M
EPS (basic) -1.07
EPS (diluted) -1.07
FCF / Share -0.71
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 962,982
Short Ratio 2.15
Short % of Float 3.40%
Beta 0.79
PE Ratio n/a
Forward PE 18.25
P/FCF Ratio n/a
PS Ratio 1.01
PB Ratio n/a
Revenue 95.93M
Operating Income 36.88M
Net Income -24.34M
Free Cash Flow -16.60M
Net Cash -92.96M
Net Cash / Share -3.94
Gross Margin 50.28%
Operating Margin 38.44%
Profit Margin -25.40%
FCF Margin -17.30%
ROA 8.53%
ROE n/a
ROIC -1.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$9.50*
(130.02% upside)
Low
7.00
Current: $4.13
High
12.00
Target: 9.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue99.2277.3571.8369.3451.95---
Revenue Growth28.28%7.67%3.6%33.46%----
Gross Profit48.2434.1933.6432.1923.90---
Operating Income25.7512.7712.27-16.42-3.28-11.87-1.09-0.88
Net Income-18.63-79.72-50.08-30.213.03-16.13-1.96-1.54
Shares Outstanding22.4120.4719.0710.728.496.240.160.16
Earnings Per Share-0.79-3.90-2.63-2.820.21-2.79-15.41-12.53
Dividend Per Share1.80-------
Operating Cash Flow-25.50-43.12-17.04-3.208.46-10.87-0.82-1.22
Capital Expenditures-8.34-7.20-5.40-3.77-2.41---
Free Cash Flow-33.84-50.31-22.45-6.976.05-10.87-0.82-1.22
Cash & Equivalents19.1538.5164.4864.4819.7819.680.010.05
Total Debt11164.2453.6024.3929.76-11.9110.16
Net Cash / Debt-91.69-25.7310.8840.10-9.9819.68-11.89-10.11
Assets11015518618313920.370.850.15
Liabilities11717515711198.351.4512.9310.28
Book Value-6.71-19.5028.8571.6140.3518.93-17.96-15.56
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Recro Pharma, Inc.
Country United States
Employees 213
CEO Gerri A. Henwood

Stock Information

Ticker Symbol REPH
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: REPH
IPO Date March 7, 2014

Description

Recro Pharma, Inc. a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products to pharmaceutical market in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was founded in 2007 and is based in Malvern, Pennsylvania.